Whereas pre- and post-treatment serum fibronectin levels were not useful for predicting tumor recurrence after curative treatment, the change in serum fibronectin levels was a prognostic factor related to outcome, which was similarly observed in the association between changes in AFP levels and outcome. Here, FN1 is linked to neoplasm.